Alector LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alector LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11311
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alector LLC (Alector) is a biotechnology company that develops therapies for immune system to cure neurodegeneration and cancer. The company discovers and develops immune modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. It combines state-of-the-art antibody technology and recent discoveries in neuroimmunology and oncology to fight cancer. Alector also generates and validates antibody drugs that engage key disease altering and genetically validated neuroimmune targets. The company develops drugs through collaborations with scientists and drug developers. It operates a manufacturing facility in Milpitas, California. Alector is headquartered in South San Francisco, California, the US.

Alector LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alector LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alector LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alector LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alector LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alector LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alector LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Alector Raises USD133 Million in Series E Venture Financing 10
Alector Raises USD29.5 Million in Series D Financing 13
Alector Raises USD32 Million in Series C Financing 15
Alector Raises Funds Through Series A Financing 17
Partnerships 18
AbbVie Enters into Agreement with Alector 18
Alector Enters Into Research Agreement With Janssen Pharma 19
Alector Enters Into Research Agreement With Adimab 20
Alector LLC – Key Competitors 21
Alector LLC – Key Employees 22
Alector LLC – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Nov 16, 2018: Alector strengthens Board of Directors with appointments of David Wehner, Richard Scheller and Louis Lavigne 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Alector LLC, Pharmaceuticals & Healthcare, Key Facts 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alector LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alector LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alector LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Alector LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alector Raises USD133 Million in Series E Venture Financing 10
Alector Raises USD29.5 Million in Series D Financing 13
Alector Raises USD32 Million in Series C Financing 15
Alector Raises Funds Through Series A Financing 17
AbbVie Enters into Agreement with Alector 18
Alector Enters Into Research Agreement With Janssen Pharma 19
Alector Enters Into Research Agreement With Adimab 20
Alector LLC, Key Competitors 21
Alector LLC, Key Employees 22
Alector LLC, Other Locations 23

List of Figures
Alector LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alector LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alector LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alector LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alector LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Alector LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HeartSciences:医療機器:M&Aディール及び事業提携情報
    Summary HeartSciences, formerly Heart Test Laboratories Inc, is a medical device company that offers cardiac care products. The company develops, manufactures and markets cardiac testing tools for the early detection of heart disease. It offers MyoVista, a screening tool used to determine the presen …
  • Keyera Corp (KEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Keyera Corp (Keyera) is a midstream oil and gas company. The company offers services such as processing, storage, transportation and marketing of oil and natural gas. It owns and operates raw gas gathering pipelines and processing plants, which collect and process raw natural gas, remove was …
  • Heineken NV:戦略・SWOT・企業財務分析
    Heineken NV - Strategy, SWOT and Corporate Finance Report Summary Heineken NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Probiogen AG-製薬・医療分野:企業M&A・提携分析
    Summary Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeu …
  • China Unicom (Hong Kong) Limited:企業の戦略・SWOT・財務情報
    China Unicom (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report Summary China Unicom (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • MetGen Oy:製薬・医療:M&Aディール及び事業提携情報
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company offers metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosic …
  • McConnell Dowell Corp Ltd:企業の戦略的SWOT分析
    McConnell Dowell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • PT ANTAM (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT ANTAM (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SOLX Inc-医療機器分野:企業M&A・提携分析
    Summary Solx Inc (SOLX) is a medical device company that develops therapeutic products. The company provides glaucoma surgery devices and treatments for glaucoma therapy. Its SOLX gold shunt is a minimally invasive device, which is used in surgical treatment of glaucoma. SOLX’s product is a gold imp …
  • Rentech Inc (RTKH)-エネルギー分野:企業M&A・提携分析
    Summary Rentech, Inc. (Rentech) is a provider of wood fibre processing services, wood chips and wood pellets. It offers a wide range of integrated wood fibre services such as wood chipping, trading, vessel loading, operations, and marketing through its subsidiary, Fulghum Fibres, primarily to the pu …
  • Tom N Toms Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Eloxx Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Eloxx Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eloxx Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Cleanaway Waste Management Ltd (CWY):企業の財務・戦略的SWOT分析
    Cleanaway Waste Management Ltd (CWY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Garmin Ltd:企業の戦略・SWOT・財務情報
    Garmin Ltd - Strategy, SWOT and Corporate Finance Report Summary Garmin Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • IDOX Plc (IDOX):企業の財務・戦略的SWOT分析
    Summary IDOX Plc (IDOX) is an information technology company that supplies and develops software solutions and information services. The company offers services such as funding, manages services, government and compliance solutions. Its government services include environmental, legal, democratic, e …
  • Just Energy Group Inc. (JE):企業の財務・戦略的SWOT分析
    Just Energy Group Inc. (JE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Newfield Exploration Co (NFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Newfield Exploration Co (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The company …
  • Lincoln Pharmaceuticals Ltd (LINCOLN):企業の財務・戦略的SWOT分析
    Lincoln Pharmaceuticals Ltd (LINCOLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Texas Roadhouse Inc (TXRH):企業の財務・戦略的SWOT分析
    Texas Roadhouse Inc (TXRH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆